Home » Newsletters » BioWorld Asia

BioWorld Asia

Sep. 26, 2001

View Archived Issues

European Commissioners Call For Leadership On GMO Issue

Singapore Plans Extensive Biotech Facilities Investment

Unrelated Gene Can Successfully Treat Muscular Dystrophy Model

EuroProteome Raises EUR9.5M To Fund Work In Cancer Proteins

ReNeuron Signs Second Deal, Says Production Snags Continue

Other News To Note

Biovector Therapeutics Reworks Business To Focus On Delivery

Autogen Patents 30 Genes Linked To Diabetes, Obesity

MPB Cologne Opposes Patent Covering Antibody Production

Sciona Granted UK Patent Covering 2,500 Gene Variants

Vernalis Shares Fall On Word Of Possible Lead-Drug Fallout

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...